Skip to main content

Table 3 Analysis of clinical characteristics in NCAN (rs2228603 C/T) carriers and non-carriers of the study populationa

From: Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study

Characteristic

Overall series

NAFLD patients

Controls

Carriers

Non-carriers

P

Carriers

Non-carriers

P

Carriers

Non-carriers

P

Age, y

44.74 ± 11.20

42.91 ± 12.01

0.234

48.58 ± 10.69

45.54 ± 11.74

0.174

41.66 ± 10.74

40.36 ± 11.75

0.524

Female/male

45/29

200/103

0.401

14/19

83/66

0.166

31/10

117/37

0.961

Height, cm

167.35 ± 7.76

166.43 ± 8.89

0.416

168.45 ± 8.20

166.89 ± 11.00

0.441

166.46 ± 7.36

166.00 ± 6.22

0.682

Weight, Kg

68.41 ± 11.77

68.70 ± 12.67

0.857

71.39 ± 10.34

74.91 ± 11.61

0.110

66.00 ± 12.41

62.69 ± 10.60

0.123

ALT, U/L

22.43 ± 12.41

22.60 ± 12.99

0.920

24.55 ± 12.09

25.87 ± 14.90

0.633

20.73 ± 12.55

19.44 ± 9.90

0.483

AST, U/L

20.68 ± 8.04

20.75 ± 9.40

0.953

20.45 ± 5.84

22.22 ± 12.09

0.415

20.85 ± 9.52

19.32 ± 5.36

0.177

GGT, U/L

17.77 ± 7.631

18.56 ± 8.872

0.479

20.67 ± 8.855

22.52 ± 9.776

0.317

15.44 ± 5.572

14.73 ± 5.735

0.482

TBIL, umol/L

13.43 ± 5.41

13.70 ± 5.97

0.725

12.28 ± 4.94

14.32 ± 6.64

0.097

14.36 ± 5.64

13.09 ± 5.19

0.174

AKP, U/L

65.18 ± 13.75

64.73 ± 17.22

0.017

69.94 ± 16.51

69.34 ± 18.60

0.070

67.95 ± 10.75

60.28 ± 14.50

0.258

Glu. mmol/L

5.04 ± 0.86

5.31 ± 1.66

0.182

5.21 ± 1.09

5.66 ± 1.90

0.194

4.91 ± 0.60

4.98 ± 1.32

0.756

UA, umol/L

307.59 ± 81.35

337.55 ± 156.11

0.111

335.42 ± 98.44

370.85 ± 201.84

0.328

285.20 ± 56.33

305.33 ± 81.03

0.136

TG, mmol/L

1.46 ± 1.28

1.65 ± 1.81

0.381

2.00 ± 1.67

1.98 ± 1.81

0.964

1.03 ± 0.57

1.34 ± 1.75

0.263

TC, mmol/L

4.80 ± 0.92

4.77 ± 0.96

0.825

4.88 ± 0.83

4.93 ± 0.98

0.799

4.73 ± 0.98

4.62 ± 0.92

0.493

HDL, mmol/L

1.47 ± 0.25

1.37 ± 0.44

0.009

1.31 ± 0.26

1.29 ± 0.50

0.861

1.60 ± 0.14

1.44 ± 0.36

0.000

LDL, mmol/L

3.04 ± 0.85

3.13 ± 0.89

0.452

3.18 ± 0.68

3.33 ± 0.98

0.403

2.94 ± 0.96

2.94 ± 0.76

0.985

  1. Abbreviations: ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT gamma-glutamyltranspeptidase, TBIL Total bilirubin, AKP alkaline phosphatase, GLU glucose, UA Uric acid, TG Triglyceride, TC Total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. aData are presented as Mean ± SD
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X